Postprogression treatment of lenvatinib plus PD‐1 inhibitor in advanced hepatocellular carcinoma refractory to hepatic arterial infusion chemotherapy
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Postprogression treatment of lenvatinib plus PD‐1 inhibitor in advanced hepatocellular carcinoma refractory to hepatic arterial infusion chemotherapy
Authors
Keywords
-
Journal
CANCER
Volume 129, Issue 14, Pages 2235-2244
Publisher
Wiley
Online
2023-04-08
DOI
10.1002/cncr.34764
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Objective response by mRECIST to initial lenvatinib therapy is an independent factor contributing to deep response in hepatocellular carcinoma treated with lenvatinib-transcatheter arterial chemoembolization sequential therapy
- (2022) Hidekatsu Kuroda et al. Liver Cancer
- Lenvatinib, toripalimab plus hepatic arterial infusion chemotherapy in patients with high-risk advanced hepatocellular carcinoma: A biomolecular exploratory, phase II trial
- (2022) ZhiCheng Lai et al. EUROPEAN JOURNAL OF CANCER
- Hepatic arterial infusion chemotherapy and sequential ablation treatment in large hepatocellular carcinoma
- (2022) Huimin You et al. INTERNATIONAL JOURNAL OF HYPERTHERMIA
- Real-World Comparative Effectiveness of Nivolumab versus Pembrolizumab in Patients with Unresectable Hepatocellular Carcinoma
- (2022) Hsin-Yu Kuo et al. Pharmaceutics
- Hepatic Arterial Infusion Chemotherapy as a Timing Strategy for Conversion Surgery to Treat Hepatocellular Carcinoma: A Single-Center Real-World Study
- (2022) Jiongliang Wang et al. Journal of Hepatocellular Carcinoma
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Improving antitumor immunity using antiangiogenic agents: Mechanistic insights, current progress, and clinical challenges
- (2021) Shu‐Jin Li et al. Cancer Communications
- Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Transarterial Chemoembolization for Large Hepatocellular Carcinoma: A Randomized Phase III Trial
- (2021) Qi-Jiong Li et al. JOURNAL OF CLINICAL ONCOLOGY
- Arterial Chemotherapy of Oxaliplatin Plus Fluorouracil Versus Sorafenib in Advanced Hepatocellular Carcinoma: A Biomolecular Exploratory, Randomized, Phase III Trial (FOHAIC-1)
- (2021) Ning Lyu et al. JOURNAL OF CLINICAL ONCOLOGY
- First-Line Systemic Treatment Strategies for Unresectable Hepatocellular Carcinoma: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials
- (2021) Wenfeng Liu et al. Frontiers in Oncology
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Potential of Lenvatinib for an Expanded Indication from the REFLECT Trial in Patients with Advanced Hepatocellular Carcinoma
- (2020) Susumu Maruta et al. Liver Cancer
- Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
- (2019) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- Simultaneous transarterial chemoembolization and radiofrequency ablation for large hepatocellular carcinoma
- (2019) Feng Duan et al. World Journal of Gastrointestinal Oncology
- Diagnosis, Staging and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
- (2018) Jorge A. Marrero et al. HEPATOLOGY
- Hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin vs. sorafenib for advanced hepatocellular carcinoma
- (2018) Ning Lyu et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- AASLD guidelines for the treatment of hepatocellular carcinoma
- (2017) Julie K. Heimbach et al. HEPATOLOGY
- NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017
- (2017) Al B. Benson et al. Journal of the National Comprehensive Cancer Network
- Post-progression survival and progression-free survival in patients with advanced hepatocellular carcinoma treated by sorafenib
- (2015) Takeshi Terashima et al. HEPATOLOGY RESEARCH
- VEGF-A modulates expression of inhibitory checkpoints on CD8+T cells in tumors
- (2015) Thibault Voron et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors
- (2014) Gregory T Motz et al. NATURE MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started